Review



bub1 inhibitor bay 320  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    MedChemExpress bub1 inhibitor bay 320
    Bub1 Inhibitor Bay 320, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bub1+inhibitor+bay+320/pmc12540835-307-0-3?v=MedChemExpress
    Average 93 stars, based on 3 article reviews
    bub1 inhibitor bay 320 - by Bioz Stars, 2026-07
    93/100 stars

    Images



    Similar Products

    93
    MedChemExpress bub1 inhibitor bay 320
    Bub1 Inhibitor Bay 320, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bub1+inhibitor+bay+320/pmc12540835-307-0-3?v=MedChemExpress
    Average 93 stars, based on 1 article reviews
    bub1 inhibitor bay 320 - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    90
    Bayer AG bay-320 inhibitor of bub1
    Action of protein kinases on components of the purified p31-TRIP13 system. (A) Effects of protein kinases on the disassembly of Cdc20-Mad2 by the purified p31-TRIP13 system. The recombinant protein kinases were added at the indicated concentrations to a reaction mixture similar to that described for MC disassembly (Materials and Methods), except that extract was replaced by TRIP13 (50 nM) and his6-p31 (0.6 nM). The plot shows values of Mad2 release from MC, relative to incubation without protein kinases. (B) Phosphorylation of components of the p31-TRIP13 system by mitotic protein kinases. The phosphorylation of the following recombinant proteins—GST-p31 (0.4 pmol), TRIP13 (0.4 pmol), and MC (10 pmol)—was determined in a reaction mixture that contained, in a volume of 10 μL: 25 mm Tris⋅HCl (pH 7.2), 15 mM MgCl2, 1 mM DTT, 1 mg/mL BSA, 60 mM β-glycerol phosphate, 15 mM p-nitrophenyl phosphate, and 0.06 mM ATP that contained 2.5 μCi [γ-32P]ATP. The indicated protein kinases were supplemented at the following concentrations (suitable for the phosphorylation of known substrate proteins): 80 nM Plk1; 0.8 nM <t>Bub1-Bub3;</t> and 1.6 nM Cdk1-Cyc B. Following incubation at 37 °C for 30 min, samples were subjected to SDS/PAGE. The incorporation of 32P-phosphate into the relevant proteins was detected by phosphor storage analysis. Electrophoretic migration positions of molecular size marker proteins (kDa) are indicated on the left side.
    Bay 320 Inhibitor Of Bub1, supplied by Bayer AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bub1+inhibitor+bay+320/pmc06575526-327-16-5?v=Bayer+AG
    Average 90 stars, based on 1 article reviews
    bay-320 inhibitor of bub1 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    Image Search Results


    Action of protein kinases on components of the purified p31-TRIP13 system. (A) Effects of protein kinases on the disassembly of Cdc20-Mad2 by the purified p31-TRIP13 system. The recombinant protein kinases were added at the indicated concentrations to a reaction mixture similar to that described for MC disassembly (Materials and Methods), except that extract was replaced by TRIP13 (50 nM) and his6-p31 (0.6 nM). The plot shows values of Mad2 release from MC, relative to incubation without protein kinases. (B) Phosphorylation of components of the p31-TRIP13 system by mitotic protein kinases. The phosphorylation of the following recombinant proteins—GST-p31 (0.4 pmol), TRIP13 (0.4 pmol), and MC (10 pmol)—was determined in a reaction mixture that contained, in a volume of 10 μL: 25 mm Tris⋅HCl (pH 7.2), 15 mM MgCl2, 1 mM DTT, 1 mg/mL BSA, 60 mM β-glycerol phosphate, 15 mM p-nitrophenyl phosphate, and 0.06 mM ATP that contained 2.5 μCi [γ-32P]ATP. The indicated protein kinases were supplemented at the following concentrations (suitable for the phosphorylation of known substrate proteins): 80 nM Plk1; 0.8 nM Bub1-Bub3; and 1.6 nM Cdk1-Cyc B. Following incubation at 37 °C for 30 min, samples were subjected to SDS/PAGE. The incorporation of 32P-phosphate into the relevant proteins was detected by phosphor storage analysis. Electrophoretic migration positions of molecular size marker proteins (kDa) are indicated on the left side.

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    Article Title: Role of Polo-like kinase 1 in the regulation of the action of p31 comet in the disassembly of mitotic checkpoint complexes

    doi: 10.1073/pnas.1902970116

    Figure Lengend Snippet: Action of protein kinases on components of the purified p31-TRIP13 system. (A) Effects of protein kinases on the disassembly of Cdc20-Mad2 by the purified p31-TRIP13 system. The recombinant protein kinases were added at the indicated concentrations to a reaction mixture similar to that described for MC disassembly (Materials and Methods), except that extract was replaced by TRIP13 (50 nM) and his6-p31 (0.6 nM). The plot shows values of Mad2 release from MC, relative to incubation without protein kinases. (B) Phosphorylation of components of the p31-TRIP13 system by mitotic protein kinases. The phosphorylation of the following recombinant proteins—GST-p31 (0.4 pmol), TRIP13 (0.4 pmol), and MC (10 pmol)—was determined in a reaction mixture that contained, in a volume of 10 μL: 25 mm Tris⋅HCl (pH 7.2), 15 mM MgCl2, 1 mM DTT, 1 mg/mL BSA, 60 mM β-glycerol phosphate, 15 mM p-nitrophenyl phosphate, and 0.06 mM ATP that contained 2.5 μCi [γ-32P]ATP. The indicated protein kinases were supplemented at the following concentrations (suitable for the phosphorylation of known substrate proteins): 80 nM Plk1; 0.8 nM Bub1-Bub3; and 1.6 nM Cdk1-Cyc B. Following incubation at 37 °C for 30 min, samples were subjected to SDS/PAGE. The incorporation of 32P-phosphate into the relevant proteins was detected by phosphor storage analysis. Electrophoretic migration positions of molecular size marker proteins (kDa) are indicated on the left side.

    Article Snippet: We thank Dr. G. Siemeister (Bayer AG) for generously providing a sample of BAY-320 inhibitor of Bub1 and Dr. A. Musacchio for baculovirus expression vector of Bub1-Bub3.

    Techniques: Purification, Recombinant, Incubation, Phospho-proteomics, SDS Page, Migration, Marker